This site uses Akismet to reduce spam. Learn how your comment data is processed.
STOCK (FUTURE / CASH / OPTION ) NIFTY (FUTURE / OPTION) BANK NIFTY (FUTURE / OPTION) FUTURE STOCK TIPS: HINDPETRO (OCT. FUT.) BUY ABOVE 426 TGT 430/435/440 S/L 425 AND SELL BELOW 425 TGT 423/421/420 S/L 426 HDFCAMC (OCT. FUT.) BUY ABOVE 4570 TGT 4600/4650/4750 S/L 4560 AND SELL BELOW 4560…
Not long ago, BCE (TSX:BCE) and its dividend were getting a lot of attention for all the wrong reasons. In 2025, the company took a significant step, one that many investors were expecting, cutting its quarterly dividend by more than 50%. For investors who saw it coming, the move was necessary. But for many others,…
After an impressive 18% gain in 2024, the TSX Composite Index has started 2025 with a bit of a stumble. It jumped out of the gate with a strong 3.3% gain in January but has since given back 1.9%, leaving the index up just 1.3% year to date. For investors, it’s a classic case of…
As paycheques grow, so do expectations—nicer cars, bigger homes, frequent upgrades, and lifestyle choices that quietly become non‑negotiable. What often goes unnoticed is how easily rising income turns into rising expenses, leaving wealth creation stuck in neutral despite years of hard work. Charlie Munger, the legendary partner of Warren Buffett at Berkshire Hathaway, frequently warned…
Sabre Insurance Group (LON:SBRE) Reaches New 1-Year Low – What’s Next? Source link
Shares of Zydus Lifesciences jumped around 6% after the company announced that its board of directors will meet on May 19 (Tuesday) to consider a buyback of shares. The pharma company also announced the acquisition of US-based cancer drug-maker Assertio for $166.4 million. Zydus Lifesciences shares climbed to an intraday high of Rs 993.80 on…